Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRYSTAL: Cetuximab + FOLFIRI in mCRC
NCT00154102Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- May 2004
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies
- Countries
- 30
01
Overview
A Phase 3 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by Merck KGaA. Started May 2004; status: completed.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00154102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154102.